Clinical Trials Logo

Filter by:
NCT ID: NCT04823130 Completed - Dermatitis Atopic Clinical Trials

Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis

DIFFEREN-STAD
Start date: April 22, 2021
Phase: Phase 4
Study type: Interventional

Primary Objective: - Assess change in neuronal architecture following long term treatment with dupilumab in skin biopsies from atopic dermatitis (AD) participants with chronic pruritus. Secondary Objectives: - Assess change in neuronal architecture following short term treatment with dupilumab and during follow-up in skin biopsies from AD participants with chronic pruritus. - To evaluate the efficacy of dupilumab in AD participants with chronic pruritus. - To evaluate the safety of dupilumab in adult participants with moderate-to-severe AD.

NCT ID: NCT04822883 Completed - Schizophrenia Clinical Trials

Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia

Start date: April 26, 2021
Phase: Phase 2
Study type: Interventional

The purpose of this study is to assess the safety and effects on electrical activity in the brain of an investigational drug (RL-007) for improving cognition in patients with schizophrenia

NCT ID: NCT04822844 Completed - Clinical trials for Postoperative Nausea and Vomiting (PONV)

Implementing a Nurse-Driven Aromatherapy Protocol to Decrease the Effect of Postoperative Nausea and Vomiting

Start date: April 1, 2021
Phase: N/A
Study type: Interventional

This is a quality improvement project that aims to assess the effect of nurse-driven administration of essential oil aromatherapy on postoperative nausea and vomiting (PONV) in patients while in the post-anesthesia care unit (PACU) after general anesthesia.

NCT ID: NCT04822597 Completed - Breast Cancer Clinical Trials

Pain Control for Breast Cancer Patients Receiving Injection of Radioactive Tracer

Start date: April 23, 2021
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the effectiveness four different pain treatments for the injection of radioactive tracer that women with breast cancer receive for sentinel lymph node biopsies. This study will include women who have been diagnosed with breast cancer and who will be undergoing sentinel lymph node biopsy with a standard injection of radioactive tracer before surgery. A participant's active participation will take place on two separate occasions. In the first occasion, a participant will complete a brief pain assessment on the day of enrollment. The rest of a participant's active participation will take place on one day (the day of surgery) and last approximately 20 minutes, after which active participation will end.

NCT ID: NCT04822545 Completed - Obesity Clinical Trials

Inpatient Referral to Comprehensive Weight Management for Patients With Obesity

Start date: May 13, 2021
Phase: N/A
Study type: Interventional

Hospitalized patients with obesity who are not already in CWM (comprehensive weight management), or not comfort care/hospice will be identified by the hospitalists then the study dietitian will consent for the patient for enrollment (and answer any question regarding diet/lifestyle) in the study. The intervention will be a CWM referral at discharge. The outcome will be what percentage of these patients go to the CWM clinic at 6 months. At 6 months, the investigators will also call each participant to get a qualitative idea of the process of inpatient referral and barriers to the CWM clinic visit. Weight loss, starting on anti-obesity medication, bariatric surgery will be assessed as a secondary outcome.

NCT ID: NCT04822493 Completed - Pain Clinical Trials

Improving Pain Perceptions After Initiating a Delivery Application

iPANDA
Start date: January 1, 2021
Phase: N/A
Study type: Interventional

The investigators of this study have developed a standardized counseling aid using an electronic mobile device to help women learn about what to expect during labor and subsequent vaginal delivery or cesarean delivery, specifically regarding pain expectations. Half of women will complete the counseling aid and the other half will receive standard counseling and care. The study aims to determine if the counseling aid improves patient satisfaction and perception of pain control.

NCT ID: NCT04822467 Completed - Clinical trials for Catheter-related Bloodstream Infection

SQ53 Disinfectant Wipes for Prevention of CRBSI

Start date: December 10, 2021
Phase: N/A
Study type: Interventional

SQ53 is a novel antimicrobial, sporicidal solution that is based on a platform of quaternary ammonium chloride compounds. It has been tested against a wide range of bacteria, viruses, spores and fungal pathogens. Extensive laboratory testing has demonstrated the effectiveness of SQ53 impregnated wipes in cleaning surfaces including catheters over a 24 hour plus time period. SQ53 also received an in vitro evaluation of the irritancy potential using a tissue engineered human skin model and was found to have no potential for skin irritation. SQ53 is available as a sterilized pack with a single wipe inside. The pack is easy to open by tearing off the top end and presenting the contents to the operator to remove under sterile conditions. The current study will be a randomized single-blinded placebo-controlled clinical trial for SQ53 wipes intended for catheter cleaning in patients receiving home parenteral nutrition.

NCT ID: NCT04822311 Completed - Depression Clinical Trials

Evaluating the Impact of Focused Muscle Contraction Therapy in Retire APF Players

GH-APF
Start date: October 24, 2019
Phase: N/A
Study type: Interventional

This study will investigate the effects of an exercise intervention on retired American professional football (APF) players. A total of 20 retired APF players (≥ 18 years of age), who suffer from chronic pain, will be enrolled. The study duration for each participants will be 18 months. Enrolled participants will perform a 18 months exercise intervention which involves 90 exercise rehabilitation training visits. In addition, participants will also be tested on various measures of health and function both at baseline (prior to intervention), at 6 months, 12 months, and 18 months (post intervention). All testing and result interpretation will be performed by trained research personnel. Participants are not University of Illinois at Chicago (UIC) participants; however, study testing visits will occur at UIC. All exercise intervention training visits will occur at Gh Fitlab.

NCT ID: NCT04822129 Completed - Clinical trials for Older Persons Interested in Improving Their Brain Health

A Comparison of Two Approaches to Developing Brain Health Programs

Start date: April 26, 2021
Phase: N/A
Study type: Interventional

This is a research study, designed to test and create new ideas that other people can use. The purpose of this research study is to evaluate two ways of helping people learn to keep their brain healthy. Research has shown that things like exercise, diet, and computer-based cognitive training (doing things that make you think and remember on a computer or tablet) may help older persons maintain their mental functioning as they get older. We want to look at two ways for people to a develop brain healthy lifestyle that they can use and even enjoy. If we find that one of the ways of developing a brain healthy lifestyle is better than the other, other older persons may be able to use it, too. When we say "brain healthy lifestyle," we mean doing things that help to keep you healthy, like exercising and following a good diet. We also mean doing things that may help you think better and maintain your thinking and reasoning as you get older.

NCT ID: NCT04821960 Completed - Anxiety and Fear Clinical Trials

Memory and Fear Study (Fear of Memory Loss Study)

Start date: May 17, 2021
Phase: N/A
Study type: Interventional

This study is a randomized control study to determine the impact of a tailored, web-based mindfulness program to reduce anxiety and increase the quality of life in older adults experiencing dementia-related fears, relative to a conventional meditation program.